ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 180 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,239,276 | -15.5% | 625,496 | -12.9% | 0.01% | -13.3% |
Q2 2023 | $2,649,892 | -18.4% | 718,128 | -26.8% | 0.02% | -31.8% |
Q1 2023 | $3,247,875 | +6.0% | 981,231 | +24.3% | 0.02% | -15.4% |
Q4 2022 | $3,062,864 | +117.4% | 789,398 | +36.1% | 0.03% | +73.3% |
Q3 2022 | $1,409,000 | – | 579,850 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |